Skip to content

Our mission is to advance precision medicine with single-cell technologies, artificial intelligence, and multiomics analysis

USZ Zurich
Inselspital
Geninus logo
Single-cell resolution icon

Single-cell resolution

We harness the richness of single-cell multiomics data to explain complex biological processes

Artificial Intelligence Icon

Artificial Intelligence

We apply AI for unbiased, innovative, sensitive, and integrative multiomics data analysis

Biomarker discovery icon

Biomarker discovery

We deliver translatable biomarker signatures related to therapy response, diagnosis or disease severity

We ensure the success of your biomarker discovery project

Cheetah

Faster time-to-insights for accelerated biomarker discovery

End-to-end single-cell data generation to data insights within a few weeks

Sensitive and specific biomarker discovery

We reach high discovery success rates with our best-in-class AI algorithm, using a sensitive, specific, indication- and data- agnostic analysis approach

Fully transparent and explainable results

Our AI platform retains single-cell resolution throughout the analysis and allows scientists to explore how genes or proteins drive predictions, thereby opening the “black box”

Scailyte is a Swiss-based start-up specialized in generating actionable insights/biosignatures from multi-omics single-cell data using AI. Our AI platform, ScaiVision, combines features to integrate different datasets, is indication- and cell-type agnostic and uses data augmentation and a cluster-free approach to extract relevant information while retaining single-cell resolution. These features result in very high discovery success rates from a limited number of samples, with actionable insights for the basis of assay development.

Cell & Gene Therapy companies icon

For Cell & Gene Therapy companies

Immunology & Oncology companies icon

For Immuno-Oncology, Inflammation and Immunology companies

Hemex

Partner Testimonials

Prof. Dr Michael Mueller

Prof. Dr Michael Mueller

Leading Clinician in Women’s Health & Scientific Advisor

“Our current collaboration with Scailyte in the field of women’s health is a truly innovative approach. We are integrating cutting edge technologies to develop biomarkers that will be the basis for impactful diagnostic solutions.”
Pascal Koenig

Pascal Koenig

Entrepreneur & Chairman of the Board of Directors

“As the co-founder and former CEO of Ava Women, I have experienced the power that big datasets have on the healthcare industry. Scailyte’s mission, proven technology and strong expertise have convinced me to join the team. I am delighted to contribute and assist in bringing Scailyte’s solution to patients around the world.”
Dominique Mégret

Dominique Mégret

Scailyte Board of Directors & Head Swisscom Ventures

“Precision medicine is poised to become a standard in the future, however today it is facing a major obstacle: a data problem. The robust analytical engine of Scailyte makes it an enabler of precision medicine. We decided to support the company because we believe in the technology, as well as in the talented team behind it.”
Prof. Woong-Yang Park

Prof. Woong-Yang Park

Founder and CEO of Geninus

“Geninus aims to implement single-cell genome analysis techniques to facilitate personalized patient care. Scailyte’s machine learning model will add value to the single-cell gene expression profile of patients. Through collaboration with Scailyte, we hope to provide prognostic methods for immunotherapy response in precision medicine clinics.”

Recent News

NextGen Omics Boston Conference

Scailyte will be attending the upcoming NextGen Omics Boston conference, taking place on March 30-31

Read more

Recent News

Vijay Tiwari is appointed as Chair of the Scientific Advisory Board

Vijay Tiwari is appointed as the Chair of Scailyte's Scientific Advisory Board

Read more

Recent News

Endometriosis interview series

We mark Endometriosis Awareness Month, and Scailyte is proud to support this cause with the “Endom

Read more

Recent News

Scailyte Announces a Collaboration with Turnstone Biologics

Scailyte Announces Collaboration with Turnstone Biologics to Identify Biomarker Signatures in Solid

Read more

Recent News

BIO-Europe Spring 2023

We will be attending the 17th annual BIO-Europe Spring taking place from 20-22 March 2023 in Basel.

Read more

Recent News

Deciphering Disease Mechanisms Through Functional Genomics

Tiwari lab studies gene-epigenetic interplay in cell identity & its disruption in cancer/neurologica

Read more

Recent News

International Women's Day 2023

Scailyte celebrates International Women’s day and praises all women Scailyters: smart, trailblazin

Read more

Recent News

Diana Stoycheva and Sarah Carl at Biomarkers 2023

We are excited to announce our attendance at Oxford Global Conferences' Biomarkers 2023! Our team, i

Read more

Recent News

01 /04

NextGen Omics Boston Conference

Scailyte will be attending the upcoming NextGen Omics Boston conference, taking place on March 30-31

Read more

Vijay Tiwari is appointed as Chair of the Scientific Advisory Board

Vijay Tiwari is appointed as the Chair of Scailyte's Scientific Advisory Board

Read more

Recent News

02 /04

Endometriosis interview series

We mark Endometriosis Awareness Month, and Scailyte is proud to support this cause with the “Endom

Read more

Scailyte Announces a Collaboration with Turnstone Biologics

Scailyte Announces Collaboration with Turnstone Biologics to Identify Biomarker Signatures in Solid

Read more

Recent News

03 /04

BIO-Europe Spring 2023

We will be attending the 17th annual BIO-Europe Spring taking place from 20-22 March 2023 in Basel.

Read more

Deciphering Disease Mechanisms Through Functional Genomics

Tiwari lab studies gene-epigenetic interplay in cell identity & its disruption in cancer/neurologica

Read more

Recent News

04 /04

International Women's Day 2023

Scailyte celebrates International Women’s day and praises all women Scailyters: smart, trailblazin

Read more

Diana Stoycheva and Sarah Carl at Biomarkers 2023

We are excited to announce our attendance at Oxford Global Conferences' Biomarkers 2023! Our team, i

Read more

Recent News